Key points are not available for this paper at this time.
“Prolonged exposure to dyslipidemia is a major determinant of lifetime ASCVD risk, but lipid screening in pediatric populations remains inconsistently implemented, with only 10-20% of children undergoing testing.”
Schubert et al. (Wed,) studied this question.